United States Flu Vaccine Market & Forecast

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Complete Report @ http://www.dpiresearch.com/report-details.php?P_ID=90

Major and Promising Vaccine covered in the report are as follows:

Fluzone High–Dose
Fluzone Quadrivalent
Intradermal (ID) Trivalent
Vaxigrip
Fluarix Quadrivalent
Flulaval Quadrivalent
Fluenz Tetra
FluMist Quadrivalent
Flublok
VN–100
M–001
VAX–2012Q
TAK – 850
Flucelvax Quadrivalent
Afluria Quadrivalent
Agrippal
Fluad
Fluvirin
Fluvax

Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Seqirus
AstraZenecca
Protein Sciences Corporation
Novavax
Daiichi–Sankyo
Mitsubishi Tanabe Pharma
BiondVax Pharmaceuticals Ltd
VaxInnate

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Tel :+91 -7289949987
Email: sales@dpiresearch.com
Website: www.dpiresearch.com

This release was published on openPR.